Aligning oral mesalazine treatment to health service priorities: guidance for nurses

Oral mesalazine represents a crucial front-line agent for the treatment of active ulcerative colitis (UC) and the maintenance of remission. Clinical aspects of mesalazine therapy are guided by robust evidence-based guidelines, although there is a relative paucity of guidance examining the specific a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kemp, Karen, Sephton, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Professional Matters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963542/
https://www.ncbi.nlm.nih.gov/pubmed/24683448
http://dx.doi.org/10.1136/flgastro-2013-100357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963542/
https://www.ncbi.nlm.nih.gov/pubmed/24683448
http://dx.doi.org/10.1136/flgastro-2013-100357

Ejemplares similares